about
Increased expression of PITX2 transcription factor contributes to ovarian cancer progressionEffectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancerEffectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancerUnexpected gynecologic findings during abdominal surgeryLaparoscopic optical coherence tomography imaging of human ovarian cancer.Tissue biomarkers in prognostication of serous ovarian cancer following neoadjuvant chemotherapy.Dysregulated expression of long noncoding RNAs in gynecologic cancers.Expression and function of androgen receptor coactivator p44/Mep50/WDR77 in ovarian cancerDiscovery of prognostic factors for diagnosis and treatment of epithelial-derived ovarian cancer from laying hens.Optical biomarkers of serous and mucinous human ovarian tumor assessed with nonlinear optics microscopies.Protein biomarkers of ovarian cancer: the forest and the treesExpression loss and revivification of RhoB gene in ovary carcinoma carcinogenesis and development.Validation of LRG1 as a potential biomarker for detection of epithelial ovarian cancer by a blinded studyParaneoplastic autoimmune hemolytic anemia in ovarian cancer: a marker of disease activity.Membranous expressions of Lewis y and CAM-DR-related markers are independent factors of chemotherapy resistance and poor prognosis in epithelial ovarian cancer.Identification of candidate biomarker mass (m/z) ranges in serous ovarian adenocarcinoma using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling.The zinc finger gene ZIC2 has features of an oncogene and its overexpression correlates strongly with the clinical course of epithelial ovarian cancer.Ovarian undifferentiated carcinoma with voluminous mesenteric presentation.Diagnostic performance of the Gynecology Imaging Reporting and Data System for malignant adnexal masses.Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health StudyOverexpression of S100A14 in human serous ovarian carcinomaCorrelation of FOXC1 protein with clinicopathological features in serous ovarian tumorsOvarian cancer: in search of better marker systems based on DNA repair defectsThe importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancer.Targeting signaling pathways in epithelial ovarian cancer.Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges.Clear Cell Adenocarcinofibroma Ovary - A Rare Histopathological Variant with Unusual Presentation.A serum based analysis of ovarian epithelial tumorigenesisKLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.BRCA1 promoter hypermethylation in sporadic epithelial ovarian carcinoma: Association with low expression of BRCA1, improved survival and co-expression of DNA methyltransferases.RETRACTED: Metastatic ovarian papillary cystadenocarcinoma to the small intestine serous surface: report of a case of high-grade histopathologic malignancy.Differentiating rectal carcinoma by an immunohistological analysis of carcinomas of pelvic organs based on the NCBI Literature Survey and the Human Protein Atlas database.Evaluation of the correlation of vasculogenic mimicry, ALDH1, KiSS-1, and MACC1 in the prediction of metastasis and prognosis in ovarian carcinoma.Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts.An on-chip Cell-SELEX process for automatic selection of high-affinity aptamers specific to different histologically classified ovarian cancer cells.The role of HE4 in ovarian cancer: inhibiting tumour cell proliferation and metastasis.International patterns and trends in ovarian cancer incidence, overall and by histologic subtype.Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer.The Prognostic Role of Optimal Cytoreduction in Advanced, Bowel Infiltrating Ovarian Cancer.Ovarian cancer stem cells: a new target for cancer therapy.
P2860
Q21090912-16111E14-36C3-4288-823E-D8430A406492Q24186388-004185D9-3FB6-4B2F-A054-CB6B226AADD2Q24187622-BA77777A-5D75-47E9-8A91-DC73A8AB9D36Q26828571-B0BCB152-21D3-4040-88E7-B09E2BD098F9Q30499394-2AE40F35-455E-4D71-A6E3-F3E0C076F315Q33594110-8405704F-A793-4E25-A138-D4F15A156B6FQ33823613-A313EA97-8F0C-440D-A71A-5B215E6D62E4Q34056207-1F09B9C1-46A5-476B-9110-F7EE1558A897Q34305434-8F4F2442-3EC0-497B-A40E-AF9C07233D7BQ34442653-D0BF6B6B-C510-46C2-B839-6DC5276BB7B6Q34634143-F6F94DB7-8906-4AC4-B990-63FB62CD0B83Q35040895-0BAE4FD7-7E2A-4257-B800-91A2BA3B6CFCQ35208879-2C2D69E7-DCD7-4C18-ADF2-EE6718519004Q35289884-F33CAFE4-88FD-4C55-91D9-53C7BAEC724EQ35402326-3726A150-4259-46F2-925A-BD2CDEA16053Q35761603-64ECBF20-4362-4BA3-B06D-8A104FDA6509Q36091016-EFA076ED-654B-4D04-9CB4-3044F06FCCACQ36220041-430A05C1-53F8-4213-A09D-8077DDDAD428Q36308518-07F5B52E-D05C-4E01-905B-8F58E3766876Q36421847-5805BED2-19E0-40E5-9FDF-EAFD298B3E44Q36524069-9BDF4FF4-80E1-42C5-B3FB-D3D0C21439D4Q36524128-5EE75EE9-F13C-4FDF-8F1A-4729CE438CAFQ36589947-E935258E-BDA4-46D9-A2F7-E3EC4A2D7CE4Q36820568-C2802420-5A4C-449C-89F2-847AFBF0D6DBQ36913614-6F2B1BA9-EA55-4387-85D1-E506E7B22E6CQ36949580-1497CF43-F17A-484B-B59B-E0F1E8DDEE53Q37102647-7B008125-9900-4884-8AEA-50F0F0349EFAQ37133800-F12009E7-C912-4EBC-AD02-4545A532D3E9Q37400530-10F82CB8-82AC-4873-B9B5-27CEF901E26CQ37652536-D1C9BD4A-CC66-4607-857C-F3F7F5488715Q37689099-0A66B3F5-91CA-4ED8-95A6-77C1BD78FDE5Q37996298-32D81D75-801E-4912-8489-74A874BC213AQ38932894-4C402172-CFB4-46BB-94F4-1F6B62A80A39Q39098568-096AC8DD-1D11-407C-A707-214F0A21C403Q39141922-A875A1FF-70E9-4E73-B2E4-06A40D37CA7AQ39437253-5C275723-7D2D-4961-A7D7-FBAD75B8D0C7Q40309521-9548F2BB-B7C8-4D77-B79C-94BC30A2F5A5Q41601838-F055C316-1BFB-46DD-B0C0-DA790EFD838FQ41615167-81A245E7-8C42-4FBE-A0E0-C9D59A57F8B5Q42092160-8594ECAB-D0E6-405D-8086-CF280DEA6112
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Histological classification of ovarian cancer.
@ast
Histological classification of ovarian cancer.
@en
type
label
Histological classification of ovarian cancer.
@ast
Histological classification of ovarian cancer.
@en
prefLabel
Histological classification of ovarian cancer.
@ast
Histological classification of ovarian cancer.
@en
P2093
P356
P1433
P1476
Histological classification of ovarian cancer.
@en
P2093
Hiroaki Kobayashi
Hitoo Nakano
Shinji Ogawa
Toshio Hirakawa
Tsunehisa Kaku
Yoshiaki Kawano
Yoshihiro Ohishi
P356
10.1007/S007950300002
P577
2003-03-01T00:00:00Z